|
|
|
|
|
by bryanrasmussen
1675 days ago
|
|
>In the years since they refused the $1M price tag in an attempt to drive a hard bargain, the national governments and private insurance companies have no doubt spent more than $1M per patient they refused to buy a dose for. I wouldn't make the assumption on that, given the disease is potentially deadly. I would more likely make the assumption that the private insurance companies especially did the math and figured they end up a couple hundred thousand ahead in the most likely scenarios. But I'm prone to cynicism. >> Also tax writeoffs exist, so I'm not sure what that R&D actually cost them? >I think you have some major misunderstandings about what tax writeoffs are and how they work. perhaps, but I do experience that sometimes in my business it can make sense to spend money on things and make less profits in order to have less taxes to pay, on paper things might look worse off but I somehow feel that I'm doing better nonetheless. |
|